$RYM

Green Thumb unit adds RYTHM (RYM) shares at $0.001

RSLGH, a subsidiary of Green Thumb Industries, exercised warrants for 133,716 RYTHM (RYM) shares at $0.001 each, acquiring 57,377 shares from a May 2025 note and 76,339 from an August 2025 note. The total value of the transactions was approximately $3.6 million.

Original reporting
Published Sep 3, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RYM
Neutral
medium confidence
Mentioned
$RYM
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$RYMNeutralLow
01

Why it matters

The insider transaction adds modest buying pressure but is unlikely to move the stock significantly.

02

Market read

Primary Form 4 disclosure with modest dollar value; limited trading relevance.

03

What to watch

Potential dilution from warrant exercises and the overall ownership structure of Green Thumb Industries.

Relevance 4/10Novelty 4/10Timing: post filing

Background

Green Thumb Industries' subsidiary RSLGH exercised warrants tied to convertible notes, increasing its stake in RYTHM.

Company-level read

Ticker impact

$RYMNeutralMedium confidence
Context

RSLGH, LLC exercised pre‑funded warrants to buy 133,716 RYTHM shares, disclosed in a Form 4 filing.

Expected impact

Potential slight upside pressure if market perceives confidence, but limited due to small transaction size.

Evidence & confidence

The transaction is a primary disclosure (Form 4) with a modest dollar amount; traders may watch for follow‑on buying but no immediate large‑scale impact.

Market effects

Minimal; limited relevance to broader cannabis sector.

None

None

Counterpoint

The purchase could be a routine capital‑structure move rather than a bullish signal.

Key entities

  • RYTHM, Inc.

    Micro‑cap cannabis company whose shares were purchased.

  • RSLGH, LLC

    Ten‑percent owner of RYTHM, indirect subsidiary of Green Thumb Industries.

Related articles

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

$RYMMed

RYTHM, Inc. Reports Second Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$ALBMed

Albemarle has surprising new reason to rally

Mizuho upgraded Albemarle (ALB) to Outperform, citing growing demand for lithium in battery energy storage systems (BESS). The firm raised its 2027 lithium demand estimate by 10% and increased ALB's price target to $130. Albemarle's Q2 earnings showed strong growth in Energy Storage sales and EBITDA, driven by higher lithium prices. The company's outlook highlights the impact of lithium pricing on its financial performance.